Molecular basis for the binding promiscuity of an anti-p24 (HIV-1) monoclonal antibody.
about
High affinity antigen recognition of the dual specific variants of herceptin is entropy-driven in spite of structural plasticityEvolutionary transition pathways for changing peptide ligand specificity and structureThe SH3 domains of endophilin and amphiphysin bind to the proline-rich region of synaptojanin 1 at distinct sites that display an unconventional binding specificityCatalytic and binding poly-reactivities shared by two unrelated proteins: The potential role of promiscuity in enzyme evolutionAnalogies between digital radio and chemical orthogonality as a method for enhanced analysis of molecular recognition events.Ways and means of coping with uncertainties of the relationship of the genetic blue print to protein structure and function in the cellVascular endothelial growth factor (VEGF) receptor II-derived peptides inhibit VEGF.Epitope mapping of trans-sialidase from Trypanosoma cruzi reveals the presence of several cross-reactive determinants.Spot synthesis: observations and optimizations.Immunoblot analysis of CD34 expression in histologically diverse neoplasmsAffinity for the cognate monoclonal antibody of synthetic peptides derived from selection by phage display. Role of sequences flanking thebinding motif.Interaction of epitope-related and -unrelated peptides with anti-p24 (HIV-1) monoclonal antibody CB4-1 and its Fab fragment.Identification by phage display of the linear continuous MRPr1 epitope in the multidrug resistance-associated protein (MRP1).Peptide design by artificial neural networks and computer-based evolutionary search.Biotin-tagged cDNA expression libraries displayed on lambda phage: a new tool for the selection of natural protein ligands.High-throughput generation of small antibacterial peptides with improved activity.Application of phage display to high throughput antibody generation and characterization.Immunoprevalence to Six Waterborne Pathogens in Beachgoers at Boquerón Beach, Puerto Rico: Application of a Microsphere-Based Salivary Antibody Multiplex Immunoassay.Thermodynamic analyses reveal role of water release in epitope recognition by a monoclonal antibody against the human guanylyl cyclase C receptor.Identification and characterization of a multispecific monoclonal antibody G2 against chicken prion proteinCoherent membrane supports for parallel microsynthesis and screening of bioactive peptides.Exquisite specificity and peptide epitope recognition promiscuity, properties shared by antibodies from sharks to humans.Evolving concepts of specificity in immune reactionsLigand recognition specificity of leukocyte integrin αMβ2 (Mac-1, CD11b/CD18) and its functional consequences.Highly specific off-target binding identified and eliminated during the humanization of an antibody against FGF receptor 4.Genetic elimination of α3(IV) collagen fails to rescue anti-collagen B cells.Immunopotentiating properties of a multispecific α-anti-idiotype antibody.Structural flexibility of small GTPases. Can it explain their functional versatility?Epitope-specificity of recombinant antibodies reveals promiscuous peptide-binding properties.Dual orientation of the outer membrane lipoprotein P6 of nontypeable haemophilus influenzae.Cellulose-bound peptide arrays: preparation and applications.Molecular Mechanism and Energy Basis of Conformational Diversity of Antibody SPE7 Revealed by Molecular Dynamics Simulation and Principal Component AnalysisPolyreactive antibodies in adaptive immune responses to viruses.Molecular determinants of polyreactive antibody binding: HCDR3 and cyclic peptides.Regions of endonuclease EcoRII involved in DNA target recognition identified by membrane-bound peptide repertoires.The sodium-dependent inorganic phosphate transporter SLC34A1 (NaPi-IIa) is not localized in the mouse brain: a case of tissue-specific antigenic cross-reactivity.Fully human antibody exhibits pan-human leukocyte antigen-DR recognition and high in vitro/vivo efficacy against human leukocyte antigen-DR-positive lymphomas.Neutralization of Virus Infectivity by Antibodies: Old Problems in New Perspectives.Identification of three gp350/220 regions involved in Epstein-Barr virus invasion of host cells.Multiple binding sites in fibrinogen for integrin alphaMbeta2 (Mac-1).
P2860
Q27349722-BAAD58CC-AD79-4B39-A696-6619C4CC57D6Q27627101-E1E94E3D-760C-4F90-B6FE-DBCE09FEC956Q28146109-733A9348-388D-4D2D-B351-CEDF236F9CDCQ28364533-C7523B1E-32E9-4855-86D8-718FF16BFA5BQ28755595-B4F50B56-7A3B-4A11-AE38-8DEF0F985C01Q30393822-37B034EE-7999-4C8C-8389-707CC5EE140EQ30636178-EF019CAA-EB86-4297-B8B3-414D61C1A6C6Q30652825-D02D0C82-0E6B-44F7-9507-988FCD3CC430Q30799288-3419BA14-7175-40C1-8990-1415A8885718Q30830891-9F9A925D-DAA8-4239-AACC-DD1802ABB50BQ30845464-5C1BE8FA-E682-4AAE-B1AB-E9F8A5018A14Q30884350-71968115-2DC7-4F5C-90BF-8478B98383E0Q31137284-9014378B-6C0D-4E07-9ACD-66706273942FQ32000547-F642858C-20E2-4D49-8A56-F109C458D3A8Q32169268-303E54D7-0277-41A8-9248-8319F31D0503Q33220258-C3C68037-30F5-4055-B3B0-499B7B6936C9Q33307783-1F43FB79-73CB-4F16-B8D0-CE75D8D9FCE7Q33619565-E205E93D-12D6-454B-B5BD-F2E9BD86942BQ33877867-4A4F942C-F42E-471F-83BE-01E3339265C5Q33977808-72308805-574B-4804-9103-ACEA1280A22FQ34080657-04D1A40F-EFDD-4D71-A611-528597A1808AQ34218267-BB940C77-2D9C-4B04-B8C0-D8D8E2115772Q34450109-5586FBB7-6CFC-45A7-B10C-69EB8A3ABE86Q35547493-6366C1B9-94DB-4430-8CC0-4FB38D8F4D55Q35556797-2DF169F0-80ED-4511-8CDF-C5880DC71B73Q35679824-ED99042C-C2EA-4161-A9B2-BB9BC4B20094Q35969898-027EAB7D-BCB6-451B-AA44-4939E9086028Q36011162-D5AD83C3-3C9A-43AF-9DAF-EBCEBD05FF93Q36620162-A7D4BA75-DDD2-4B8A-BBD3-514AC62610F4Q36970929-EC3D6E91-1C3A-4F16-9A64-5A7C5480303EQ37024675-1B870141-08E8-4782-8A88-6BBF5DD9B292Q37405719-B31E7525-98E0-4065-A898-278E78DBE5E2Q37951868-B4CD34FB-4182-4ABE-B2B1-8FC013F58C1CQ38317267-09859C56-E55C-4D0F-864C-049E9AC92C11Q38328208-2D43A3FC-2FE1-4813-A35B-E610649491AEQ38820521-CA07E2C8-4CD6-440F-B7AD-9AA148F4B707Q40146896-AC4EEF3E-ED9F-4621-A27E-1B156B612940Q40295939-D0B4BBE4-1CA9-4F54-B7B5-FEE0D56A1C53Q40387241-37D2DB2A-E788-4FC8-804A-E5F0AF7365EBQ40526641-9C4F574C-5D0C-4EF8-8D74-E721B87463F3
P2860
Molecular basis for the binding promiscuity of an anti-p24 (HIV-1) monoclonal antibody.
description
1997 nî lūn-bûn
@nan
1997 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Molecular basis for the binding promiscuity of an anti-p24 (HIV-1) monoclonal antibody.
@ast
Molecular basis for the binding promiscuity of an anti-p24 (HIV-1) monoclonal antibody.
@en
type
label
Molecular basis for the binding promiscuity of an anti-p24 (HIV-1) monoclonal antibody.
@ast
Molecular basis for the binding promiscuity of an anti-p24 (HIV-1) monoclonal antibody.
@en
prefLabel
Molecular basis for the binding promiscuity of an anti-p24 (HIV-1) monoclonal antibody.
@ast
Molecular basis for the binding promiscuity of an anti-p24 (HIV-1) monoclonal antibody.
@en
P2093
P1433
P1476
Molecular basis for the binding promiscuity of an anti-p24 (HIV-1) monoclonal antibody.
@en
P2093
Schneider-Mergener J
Stöcklein W
P304
P356
10.1016/S0092-8674(00)80468-7
P407
P577
1997-12-01T00:00:00Z